Tag Archives: Pharma

IMCD to acquire Indonesian Distributor PT Megasetia

Leave a comment

Further enhanced Footprint in Life Sciences in the Asia-Pacific Region

Specialty chemicals and food ingredients distributor IMCD N.V. (Rotterdam, The Netherlands) has announced that IMCD Indonesia has signed an agreement to acquire 100% of the shares of PT Megasetia Agung Kimia [“Megasetia”] (Jakarta, Indonesia), a distributor of specialty ingredients for the Life Sciences sectors. The transaction will take place in two tranches, with IMCD now acquiring 70% of the share capital and the remaining 30% in 2025.

 

Founded in 1995, Megasetia today has three laboratories, six offices, and six warehouses across Indonesia. Its main activity is the distribution of speciality ingredients for the Pharmaceuticals Industry in Indonesia. In addition, it covers the Personal Care, Home Care, Animal Health, and certain industrial markets. With 160 employees, the company generated revenues of approximately IDR 974 bn (ca. EUR 60 mn) in 2020. It currently serves more than 1’000 customers and represents over 50 ingredients producers from around the world. IMCD said the acquistion is a an execllent fit with the groups Life Science strategy and provides a significant platform for further growth in the Life Science segments in Indonesia.

No further financial details were disclosed on the transaction, which expected to be closed in December.

Source: IMCD press release

 

HGE – DCG / 18.11.2021

Azelis to acquire Paris based Quimdis S.A.S.

Leave a comment

Specialties Distribution Group takes part in further Consolidation of Life Sciences Ingredients Distribution in EMEA

Specialty chemicals and food ingredients distributor Azelis S.A. (Munsbach, Luxembourg) has  announced that it has signed an agreement to acquire Quimdis S.A.S. (Levallois-Perret (Paris),  France), a distributor of ingredients for Nutraceuticals, Flavors & Fragrances, Animal Nutrition, Personal Care, Pharma and Food. Besides enhancing the position of Azelis France in the life sciences sector, Azelis expects the acquisition to strengthen its offering to fast-growing and attractive markets, the ananouncent said.

 

Quimdis was founded in 1988 by Jean-François Quarré, Michel Manalt and Claire Couratier, originally focusing on essential oils and active ingredients. Today the activities include ingredients distribution and formulation development in the French market and sales to more than 45 countries. Quimdis holds Ecocert, ISO 9001: 2015 and ISO 22000: 2005 approvals and certifications. The company has sales close to EUR 100 mn and its 78 employees serve over 1’000 customers and ca. 400 suppliers. Mr. Quarré will remain in his position to support the transition of Quimdis to Azelis. 

 

No financial information was disclosed on the transaction, which is expected to be completed by end of August, according to Azelis’ press release.

 

Source: Azelis press release

 

HGE – DCG / 23.07.2021

LEHVOSS Group forms JV with Engredo in Denmark

Leave a comment

Hamburg based Distributor strengthens Nutrition & Pharma Activities in the Nordic Region

Privately owned distributor of speciality chemicals and ingredients Lehmann&Voss&Co. [LEHVOSS Group] (Hamburg, Germany) has recently entered into a Joint Venture with Engredo ApS (Vejle, Denmark) in order to expand and strengthen its business activities regarding Ingredients and Minerals for the Nutritional Supplements, Pharmaceuticals and Feed sectors in the Nordic region.

The new JV allows for the synergistic combination of product portfolios as well as regulatory and sourcing expertise, LEHVOSS said in a statement. No financial details were disclosed on the transaction.

 

Source: LEHVOSS press release

 

HGE – DCG / 04.06.2021

 

 

IMCD to divest Nutri Granulations Business in the U.S.

Leave a comment

International Distributor finds new Owner for Manufacturing Facility in California

Specialty chemicals and food ingredients distributor IMCD N.V. (Rotterdam, The Netherlands) has announced that it has reached an agreement to sell its Nutri Granulations manufacturing asset and associated business to Huber Engineered Materials [“HEM”] (Atlanta, GA – United States), a division of J.M. Huber Corporation [“Huber”] for an undisclosed sum.

 

The manufacturing facility is located in La Mirada, CA and has 22 employees. Nutri Granulations manufactures both, food grade and USP grade Calcium Carbonate granulations for the Nutraceuticals, Food, Over-the-Counter, and Pharmaceuticals markets. It was taken over by IMCD as part of the acquisition of U.S. west coast distributor E.T. Horn in 2018.

 

Closing of the transaction is planned for the end of March 2021, the announcement said.

 

Source: IMCD press release

 

HGE – DCG / 10.03.2021

IMCD to acquire Mexican Distributors Millikan and Banner Química

Leave a comment

Guenther Eberhardguenther

Further Momentum for IMCD’s Growth Plans in Mexico

Specialty chemicals and food ingredients distributor IMCD N.V. (Rotterdam, The Netherlands) has announced the acquisition of Millikan S.A. de C.V. [“Millikan”] and Banner Química S.A. de C.V. [“Banner Química”] (Mexico City, Mexico), two distributors of specialty chemicals. This follows the establishment of IMCD Mexico in April 2020, a company that serves the Pharmaceuticals, Food, Nutrition and Personal Care industries.

 

Millikan was established in 1998 and offers technical support and commercial expertise to customers in the Food, Nutrition, Pharmaceuticals and Industrial markets. Banner Química, set up in 2009, has a history in providing  formulations and solutions for Personal Care and Home Care.

 

The two companies collectively generated revenues of USD 15 mn (ca. EUR 13.1 mn) in 2019 and will add 60 employees to the IMCD Mexico team, the announcement said. IMCD’s technical capabilities will also be enhanced through the addition of Food and Personal Care laboratories. No financial details were disclosed on these two transactions.

 

Source: IMCD press release

 

HGE – DCG / 07.12.2020

Caldic to acquire Brand-Nu Laboratories and BNL Sciences in Transatlantic Deal

Leave a comment

Rotterdam-based Distributor to expand global (Bio)pharmaceutical Activities

International producer and distributor of food ingredients and chemicals, Caldic B.V. (Rotterdam, The Netherlands) has announced that it has signed an agreement to acquire Brand-Nu Laboratories Inc. [“Brand-Nu”] (Meridien, Connecticut – United States) and its subsidiary BNL Sciences Ltd. [“BNL Sciences”] (Naas , Co. Kildare – Ireland), two distributors of high purity specialty chemicals and biological raw materials.

Privately-owned Brand-Nu was set up in 1956. The company serves customers in the Pharmaceutical, Biopharmaceutical, Medical Device and Microelectronic industry with a range of high purity chemicals, excipinets and biological raw materials, Caldic said in the statement. BNL Scienes was established in 2003 and caters to Biopharmaceutical, Pharmaceutical and Medical Device producers. The leadership teams around John Gorman, President of Brand-Nu will continue to work in the business.

No financial details were disclosed on the transaction, which is expected to close by end of the year, subject to certain customary closing conditions and regulatory approvals.

Source: Caldic press release

HGE – DCG / 23.10.2020

 

IMCD to acquire Indian Pharma Excipients Distributor Signet

Leave a comment

Further Pharma Growth for IMCD in Asia-Pacific and Middle East, Africa

Specialty chemicals and food ingredients distributor IMCD N.V. (Rotterdam, The Netherlands) announced yesterday that it will acquire 100% of Signet Excipients Private Limited [“Signet”] (Mumbai, Maharashtra – India), one of the leading distributors of excipients in India, in a two-phase transaction. IMCD will now acquire 70% of the share capital from the founders, and the remaining 30% by 2024. Harish Shah, Founder and Managing Director oft Signet, will continue to lead the company post completion of the first phase.

Since its foundation in 1986, Signet grew from a small distribution company to one of the leading distributors of excipients in India, the anouncement said. The company focusses on the distribution of Pharmaceutical, Nutraceutical and Bio-pharma Excipients across a range of categories such as Diluents, Fillers, Sweeteners, Disintegrants, Binders, Surfactants and others. Besides sales in India, Signet is also active in Bangladesh, the Middle East and Africa,  currently serving more than 900 customers, with more than 400 products from leading excipient producers. With approximately 100 employees, Signet generated revenue of ca. EUR 152 mn (INR 13.2 bn) in the last twelve months (up to and including June 2020), and realised a normalised EBITA of ca. EUR 39 million (INR 3.4 bn).

IMCD said it considers Signet to be well aligned with the IMCD business model and strategy, providing a significant platform for further growth in India and the Asia-Pacific region, giving the transaction a strong strategic rationale.

Closing of the transaction is subject to customary closing conditions and regulatory approval. It is expected to take place in Q4-2020. No financial details were disclosed on this transaction.

Source: IMCD press release

DistriConsult comment: In a separate anouncement today IMCD said, to finance the purchase of the first tranche of 70% of the shares of Signet, it has successfully raised ca. EUR 400 mn through an accelerated bookbuild offering of new shares. Any surplus will be used for “general corporate purposes”.

HGE – DCG / 16.09.2020

IMCD to acquire Siyeza in South Africa

Leave a comment

Further enhanced Pharma Industry Coverage for Rotterdam based Distribution Group

Specialty chemicals and food ingredients distributor IMCD N.V. (Rotterdam, The Netherlands) announced earlier this week that it has signed an agreement to acquire 100% of the shares in ingredients distributor Siyeza Fine Chem Propriety Limited [“Siyeza”] (Johannesburg, South Africa).

Founded in 2007, the company is a leading distributor of Pharmaceutical, Veterinary, Food and Personal Care speciality chemical ingredients in South Africa, IMCD said in the announcement. The company has 27 employees and generated revenues of EUR 11.7 mn in 2019. It represents producers from Europe and Asia.

 

Closing of the transaction is subject to a regulatory review. It is expected for December 2020. The company will continue with its present management and staff.

 

No financial details were disclosed on this transaction.

 

Source: IMCD press release

 

HGE – DCG / 04.09.2020

IMCD to acquire Shanghai-based Pharmaceutical Ingredients Business from Develing International Trade

Leave a comment

Dutch Distribution Group enhances Pharma Industry Coverage in China

Specialty chemicals and food ingredients distributor IMCD N.V. (Rotterdam, The Netherlands)  announced that it has signed an agreement to acquire the Pharmaceutical Business in China of Develing International Trade (Shanghai) Co. Ltd. (“Develing”) (Shanghai, China) for an undisclosed sum.

 

Develing International, with head office in Shanghai, is a Dutch sales and distribution company (B2B) of high-quality ingredients for the Food, Pharmaceutical, Chemical, and Feed industry in China and Vietnam. Its holding office is located in Bunschoten-Spakenburg, The Netherlands. The group has a number of subsidiaries in China, Vietnam and the United States. With a staff of more than 90 employees it realises sales in excess of EUR 120 mn per annum.

 

The acquired business, representing sales of approx. EUR 10 mn annually, will be integrated into IMCD China’s business unit Pharma. There will be synergies with IMCD’s existing product range, the company said in the announcement.

 

No financial details were disclosed on this transaction, which is subject to a number of closing conditions being fulfilled.

 

Source: IMCD press release, Develing website, DistriConsult analysis

 

HGE – DCG / 15.05.2020

Univar Solutions expands Pharmaceutical Ingredients Vertical to EMEA

Leave a comment

U.S. based Distributor with global Approach to Pharma Ingredients

Global chemicals and ingredients distributor Univar Solutions, Inc. (Downers Grove, IL – United States) announced that the company will extent its business for Pharmaceutical Ingredients as a “Dedicated Industry Vertical” into the Europe, Middle East and Africa (“EMEA”) region from the original regions North America and Latin America. The new industry vertical team will move on from what Matthew Ottaway, Vice President Focused Industries in EMEA said was “historically a greater emphasis on the regional market”. 

The other industry verticals at Univar are Beauty & Personal Care, Food Ingredients and Coatings, Adhesives, Sealants and Elastomers (often referred to as “CASE”). 

 

Source: Univar press release

HGE – DCG / 28.02.2020

IMCD to acquire Zifroni Chemical Suppliers Ltd. in Israel

Leave a comment

Dutch Distributor starts Year with Acquisition for Pharma and Personal Care Chemicals

Specialty chemicals and food ingredients distributor IMCD N.V. (Rotterdam, The Netherlands)  announced that it has successfully completed the acquisition of Zifron Chemical Suppliers Ltd. [“Zifroni”] (Rishon LeTsyon – Israel) for an undisclosed amount. According to IMCD’s announcement, Zifroni is a leading distributor in Israel with a focus on specialty chemical products for Pharmaceuticals and Personal Care.

 

Founded in 1950, the company generated revenues of   EUR 10.2 mn with 9 employees in 2019. The current Managing Directors, Rafi and Moshe Zifroni, and the rest of the staff will continue to work in the company, IMCD said in the statement.

 

No financial details were disclosed on the transaction.

 

Source: IMCD press release

 

HGE – DCG / 17.01.2020

Azelis to acquire Mexican Distributor Megafarma

Leave a comment

Entry into Latin America for Azelis with Acquisition in Mexico

Specialty chemicals and food ingredients distributor Azelis S.A. (Munsbach, Luxembourg) has announced that it has signed an agreement to acquire 100% of the outstanding shares of Megafarma S.A. de C.V. (Mexico City, mexico), a specialty chemicals distributor for the Pharmaceutical, Veterinary and Food Industries in all regions of Mexico

Megafarma was established in 1973. Besides its head office in Mexcio City, it has locations in Guadaljara and Monterrey.

No financial information was disclosed on the transaction, which is expected to close in the coming months.

Source: Azelis press release, Megafarma website

HGE – DCG / 18.12.2019

IMCD has acquired Colombian Pharma Distributor Unired Químicas

Leave a comment

Third Acquisition this Month for IMCD further enhancing Presence in the Pharma Sector

Specialty chemicals and food ingredients distributor IMCD N.V. (Rotterdam, The Netherlands)  announced that it has acquired 100% of the outstanding shares of specialty chemicals and ingredients distributor Unired Químicas SAS  (Bogota, Colombia). 

 

Unired serves customers in the Pharmaceutical, Food and Personal Care markets. Founded in 1991, the company generated revenues of USD 8 mn with 15 employees in 2018.

 

No financial details were disclosed on the transaction. The acquired company will be fully integrated into IMCD’s organisation during 2020.

 

Source: IMCD press release, Unired website

 

HGE – DCG / 22.11.2019

Specialty Chemicals Distributor Quadra Chemicals acquires PlusPharma in the U.S.

Leave a comment

Canadian Distributor bolsters its U.S. Presence for Pharma and Nutrition Ingredients

Family owned speciality chemicals distributor Quadra Chemicals Ltd. (Vaudreuil-Dorion, Quebec – Canada) recently announced that the company has acquired PlusPharma, Inc. (Vista, California – United States), a privately held distributor of specialty ingredients for the Pharmaceutical and Nutritional Supplements markets.

The acquired company has been active for over 30 years, Quadra said in a statement. It has a technical support team that is “assisting customers by offering formulation advice, troubleshooting production challenges, and conducting on-site training.”

Quadra had first expanded from Canada into the United States in 2016, when it set up its U.S. subsidiary Quadra Chemicals, Inc. (Woodlands, Texas – United States), which represents the company’s Reseources Division,  responsible for both the Mining and Energy Groups.

Source: Quadra press release

HGE – DCG / 11.11.2019

IMCD to acquire significant Share in Korean Distributor Whawon Pharm Co. Ltd.

Leave a comment

Second Acquisition within one Week helps to further enhance IMCD’s Coverage of Pharma Sector

Specialty chemicals and food ingredients distributor IMCD N.V. (Rotterdam, The Netherlands)  announced that it has signed an agreement to acquire 57% of the outstanding shares of pharmaceutical ingredients distributor Whawon Pharm Co. Ltd. [“Whawon”] (Seoul, South Korea). According to IMCD’s announcement, Whawon is a leading distributor in South Korea with a focus on Pharmaceutical Formulation Ingredients. Founded in 1998, the company generated revenues of KRW 57 bn (approx. EUR 44 mn) with 54 employees in 2018.

Initially, IMCD will acquire 57% of the total share capital from the existing Whawon management, who will continue to lead the company. The remaining 43% will be held by management for a period up to five years after closing.

No financial details were disclosed on the transaction, which is subject to fulfillment of certain closing conditions.

Source: IMCD press release

HGE – DCG / 05.11.2019

IMCD to acquire DCS Pharma AG in Switzerland

Leave a comment

Existing IMCD Excipients Offering to be augmented with strong API Presence of newly acquired Entity

Specialty chemicals and food ingredients distributor IMCD N.V. (Rotterdam, The Netherlands)  announced that it has signed an agreement to acquire 100% of the outstanding shares of DCS Pharma AG (Basel, BS – Switzerland) in a two-step process for an undisclosed sum. 90% of the shares will be acquired at the closing of the transaction, the remaining 10% ca. two years later, effective 31. December 2021.

DCS Pharma, a distributor of Active Pharmaceutical Ingredients (“APIs”), traces its roots back to two Swiss distributors of products  for the pharma and the nutraceutical industry, the Pharma business of Dolder AG and ChemSwiss AG, which were merged in 2016. Today the company operates with a total of 64 employees in seven countries besides Switzerland, including Spain, Italy, Germany, Mexico and China. In 2018, it generated sales of CHF 68 mn, IMCD said in a statement.

IMCD further said it expects formulation and marketing synergies between the newly acquired API activities and its existing business, which is mainly focused on Excipients. Customers of DCS Pharma should benefit from a significantly increased network, according to its CEO Beat Berger.

No financial details were disclosed on the transaction, which is subject to fulfilling customary closing conditions.

Source: IMCD press release

HGE – DCG / 01.11.2019